{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:55:03Z","timestamp":1767650103361,"version":"3.40.5"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Low dose radiation therapy (LDRT) has been used for non-malignant conditions since early 1900s based on the ability of single fractions between 50\u2013150 cGy to inhibit cellular proliferation. Given scarcity of resources, poor access to vaccines and medical therapies within low and middle income countries, there is an urgent need to identify other cost-effective alternatives in management of COVID-19 pneumonia. We conducted a pilot phase Ib\/II investigator-initiated clinical trial to assess the safety, feasibility, and toxicity of LDRT in patients with severe COVID-19 pneumonia at the Aga Khan University Hospital in Nairobi, Kenya. Additionally, we also assessed clinical benefit in terms of improvement in oxygenation at day 3 following LDRT and the ability to avoid mechanical ventilation at day 7 post LDRT.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Patients with both polymerase chain reaction (PCR) and high-resolution computer tomogram (HRCT) confirmed severe COVID-19 pneumonia, not improving on conventional therapy including Dexamethasone and with increasing oxygen requirement were enrolled in the study. Patients on mechanical ventilation were excluded. Eligible patients received a single 100cGy fraction to the whole lung. In the absence of any dose limiting toxicity the study proposed to treat a total of 10 patients. The primary endpoints were to assess the safety\/feasibility, and toxicity within the first 24 hours post LDRT. The secondary endpoints were to assess efficacy of LDRT at Day 3, 7, 14 and 28 post LDRT.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Ten patients were treated with LDRT. All (100%) of patients were able to complete LDRT without treatment related SAE within the first 24 hours post treatment. None of the patients treated with LDRT experienced any acute toxicity as defined by change in clinical and respiratory status at 24hr following LDRT. Majority (90%) of patients avoided mechanical ventilation within 7 days of LDRT. Four patients (40%) demonstrated at least 25% improvement in oxygen requirements within 3 days. Six patients (60%) were discharged and remained off oxygen, whereas four progressed and died (1 due to sepsis and 3 in cytokine storm). Median time to discharge (n = 6) was 16.5 days and median time to death (n = 4) was 11.0 days. Patients who ultimately died showed elevated inflammatory markers including Ferritin, CRP and D-dimers as compared to those who were discharged alive.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>LDRT was feasible, safe and shows promise in the management of severe COVID-19 pneumonia including in patients progressing on conventional systemic treatment. Additional phase II trials are warranted to identify patients most likely to benefit from LDRT.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0270594","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T17:38:37Z","timestamp":1656697117000},"page":"e0270594","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["A pilot phase Ib\/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from Africa"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0209-8630","authenticated-orcid":true,"given":"Mansoor","family":"Saleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0798-0745","authenticated-orcid":true,"given":"Karishma","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-5426","authenticated-orcid":true,"given":"Jasmit","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrok","family":"Karsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Waweru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Musumbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-5012","authenticated-orcid":true,"given":"Reena","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innocent","family":"Abayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureen","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Gondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sehrish","family":"Rupani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Kirathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heldah","family":"Amariati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"pone.0270594.ref001","doi-asserted-by":"crossref","first-page":"110493","DOI":"10.1016\/j.biopha.2020.110493","article-title":"Natural history of COVID-19 and current knowledge on treatment therapeutic options","volume":"129","author":"WG Dos Santos","year":"2020","journal-title":"Biomed Pharmacother"},{"unstructured":"COVID-19 CORONAVIRUS PANDEMIC 2021 [Available from: https:\/\/www.worldometers.info\/coronavirus\/.","key":"pone.0270594.ref002"},{"issue":"1","key":"pone.0270594.ref003","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202006-2405OC","article-title":"Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis","volume":"203","author":"ZJ Lim","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"19","key":"pone.0270594.ref004","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19\u2014Final Report","volume":"383","author":"JH Beigel","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"pone.0270594.ref005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"P Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0270594.ref006","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections","volume":"15","author":"J Machhi","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"issue":"11","key":"pone.0270594.ref007","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/17476348.2020.1804365","article-title":"Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis","volume":"14","author":"SS Hasan","year":"2020","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"pone.0270594.ref008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia","volume":"384","author":"C Salama","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0270594.ref009","first-page":"1241","article-title":"Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1","volume":"181","author":"X Mariette","year":"2021","journal-title":"Randomized Clinical Trial. JAMA Intern Med"},{"issue":"2","key":"pone.0270594.ref010","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1148\/radiol.2020200642","article-title":"Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases","volume":"296","author":"T Ai","year":"2020","journal-title":"Radiology"},{"issue":"13","key":"pone.0270594.ref011","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19\u2014Navigating the Uncharted","volume":"382","author":"AS Fauci","year":"2020","journal-title":"N Engl J Med"},{"issue":"10229","key":"pone.0270594.ref012","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"P Mehta","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"pone.0270594.ref013","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/09553000701317358","article-title":"Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy","volume":"83","author":"F R\u00f6del","year":"2007","journal-title":"Int J Radiat Biol"},{"issue":"3","key":"pone.0270594.ref014","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s13246-020-00915-x","article-title":"Low dose radiation therapy for COVID-19 pneumonia: brief review of the evidence","volume":"43","author":"PE Metcalfe","year":"2020","journal-title":"Phys Eng Sci Med"},{"issue":"1","key":"pone.0270594.ref015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2021.08.029","article-title":"Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of Pneumonitis","volume":"112","author":"MR Jackson","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"pone.0270594.ref016","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ijrobp.2021.03.022","article-title":"Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia","volume":"110","author":"L Meziani","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"pone.0270594.ref017","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1002\/cncr.33130","article-title":"Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial","volume":"126","author":"CB Hess","year":"2020","journal-title":"Cancer"},{"key":"pone.0270594.ref018","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.radonc.2021.10.003","article-title":"Whole-lung low-dose radiation therapy (LD-RT) for non-intubated oxygen-dependent patients with COVID-19-related pneumonia receiving dexamethasone and\/or remdesevir","volume":"165","author":"CB Hess","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1126","key":"pone.0270594.ref019","doi-asserted-by":"crossref","first-page":"20210187","DOI":"10.1259\/bjr.20210187","article-title":"Low-dose radiation therapy for COVID-19 pneumonia: a pilot study","volume":"94","author":"DN Sharma","year":"2021","journal-title":"Br J Radiol"},{"issue":"4","key":"pone.0270594.ref020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijrobp.2020.11.065","article-title":"Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Final Results of a Pilot Study","volume":"109","author":"A Ameri","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"pone.0270594.ref021","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2020.11.049","article-title":"Low-Dose Radiation Therapy in the Management of Coronavirus Disease 2019 (COVID-19) Pneumonia (LOWRAD-Cov19): Preliminary Report","volume":"109","author":"N Sanmamed","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"unstructured":"Ministry of Health. NATIONAL GUIDELINES FOR CANCER MANAGEMENT KENYA. 2013 August 2013.","key":"pone.0270594.ref022"},{"year":"2021","author":"B. Osunga MM","journal-title":"Modelling COVID-19 Risk in Kenya To Enhance Humanitarian Response","key":"pone.0270594.ref023"},{"issue":"2","key":"pone.0270594.ref024","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.afjem.2021.01.001","article-title":"A baseline review of the ability of hospitals in Kenya to provide emergency and critical care services for COVID-19 patients","volume":"11","author":"BW Wachira","year":"2021","journal-title":"Afr J Emerg Med"},{"issue":"4","key":"pone.0270594.ref025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004159","article-title":"Examining unit costs for COVID-19 case management in Kenya","volume":"6","author":"E Barasa","year":"2021","journal-title":"BMJ Glob Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T17:39:07Z","timestamp":1656697147000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270594"}},"subtitle":[],"editor":[{"given":"Randall J.","family":"Kimple","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0270594","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}